This inventor holds 1 USPTO granted patent. Top assignee: Inozyme Pharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Paul Stabach: Innovator in Soluble ENPP1 Proteins
Introduction
Paul Stabach is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of biochemistry, particularly in the development of soluble ENPP1 proteins. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Paul Stabach holds a patent for "Soluble ENPP1 Proteins and Uses Thereof." This patent highlights his research and development efforts in creating proteins that have potential therapeutic applications. The patent reflects his commitment to addressing medical challenges through innovative solutions. He has 1 patent to his name.
Career Highlights
Stabach is currently employed at Inozyme Pharma, Inc., where he continues to work on groundbreaking research. His role at the company allows him to collaborate with other talented professionals in the field. His career is marked by a focus on developing treatments that can improve patient outcomes.
Collaborations
One of his notable coworkers is Demetrios Braddock. Together, they contribute to the innovative environment at Inozyme Pharma, Inc. Their collaboration fosters a culture of creativity and scientific inquiry.
Conclusion
Paul Stabach is a dedicated inventor whose work on soluble ENPP1 proteins exemplifies the spirit of innovation in the medical field. His contributions are paving the way for future advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile